How Immunotherapy is Used as a Way to Get More Revenues From Patients at End of Life

Table of Contents: Select a Link to be Taken to That Section

Executive Summary

When patients have been subjected to ineffective cancer treatments, often the final treatment recommended is immunotherapy.
Rather than being an effective treatment, allowing the cancer center to perform more billing to the insurance company is usually recommended.

Wait One Second...

Why is The Article Not Viewable?

You are seeing this text instead of the article because of two potential reasons.

Reason #1: You are a Subscriber but Not Signed In

The only reason this should happen is if you are using a different device than the one you signed up with. You can sign in by simply sending yourself a link to the email you signed in with by selecting the link below.

You can read any article on the site as soon as you sign in.

Reason #2: You Are Not Yet Subscribed to the Site

This is a subscription site. That is how we pay for the research we do. We have to charge subscribers to access articles because, unlike WebMD, Healthline, or the Mayo Clinic, we don't allow pharmaceutical companies to write or edit our articles.

You can access this and many other articles by becoming a subscriber.

How Do You Subscribe?

See the following article, which explains what you get with a subscription.

You can be reading this article and many others like it in just a few minutes from now.